Deutsch
Contact
Press
Easy language
Logo des Deutschen Krebsforschungszentrums
de
Easy language
Search
Search
About us
back
About us
Who we are
back
Who we are
Our Mission and Values
Facts and Figures
Your way to us
Locations
Organization and Management
back
Organization and Management
Management Board
Staff Units
Administration
Committees
Advisory Councils
Donations and Wills for Cancer Research
back
Donations and Wills for Cancer Research
Donate now
Donation impact
Donation campaigns
Research
back
Our Research
Research Topics
back
Research Topics
Cell and Tumor Biology
Functional and Structural Genomics
Cancer Risk Factors and Prevention
Immunology, Infection and Cancer
Imaging and Radiooncology
Research Groups A-Z
Scientific Core Facilities and Services
Translational Centers
back
Translational Centers
National Center for Tumor Diseases (NCT)
German Cancer Consortium (DKTK)
Hopp Children’s Cancer Center Heidelberg (KiTZ)
Helmholtz Institute for Translational Oncology (HI-TRON Mainz)
DKFZ Hector Cancer Institute at University Medicine Mannheim
National Cancer Prevention Center
Transfer
back
Transfer
Innovation Management
Clinical Trial Office
Cancer Information Service
Translational Research
Patient Involvement in Cancer Research
H3 Health Hub - A Helmholtz-Transfer Academy
Cooperations
back
Cooperations
National cooperations
International Cooperation
Career
back
Career
Jobs
DKFZ as an Employer
Vocational training, studies and internships
Trainee program in administration
International Staff Services
Career Service
Cancer Research Academy
back
Cancer Research Academy
Major Cancer Biology (MSc)
International PhD Program
International Postdoc Program
Clinician Scientist Program
Junior Research Groups
Life Science Lab
Alumni Relations
News
back
News
Press Releases
Events
back
Events
German Cancer Research Congress
Rental of conference facilities
Calls for tenders
Topics in focus
einblick
Download area for journalists
Media library
Donate
Contact
Press
Donate
Donate
Open or close main menu
Home
Research
INFORM - INdividualized Therapy FOr Relapsed Malignancies in Childhood
INFORM2 (clinical trials)
Selected publications
INFORM2 (clinical trials)
Selected publications
Selected
publications
2020 -
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies
2022 -
Phase I results of the INFORM2 combination study of nivolumab and entinostat in children and adolescents: INFORM2 NivEnt.
Form
Form data is loaded ...